HealthCare Market Analysis

The global  disposable medical sensors market  is expected to reach USD 12.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases has been observed to be a major factor driving growth which is demanding for better healthcare service provision by high quality diagnostic and monitoring devices. These devices will enable patients to self-monitor and along with easy and affordable usage. In addition, the rapidly rising technological advancements is expected to bring in innovation in medical sensors. The market is also being driven by government initiatives to fund and encourage R&D which in turn will help in launching innovative products. For instance, the government of India increased the health expenditure from 1.4% to 2.5% for innovations, and other healthcare services. Innovations in medical sensors not only instill ease of use but also assist in making the device portable and automated. On the basis of...

Global  disposable medical sensors market  is expected to reach USD 7,543.1 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of HAIs (hospital acquired infections) and government initiatives aimed at reducing central-line associated bloodstream infections and surgical site infections in ward located and ICU patients are expected to serve the market as high impact rendering drivers. Introduction and subsequent rise in usage rates of novel technologies such as cancer tracking sensors, Hba1c sensors and MEMS pressure sensors is expected to boost future market growth. Strip sensors dominated the overall product segment in terms of revenue and were valued at USD 1,800.2 million in 2013. Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders and the consequent rise in demand for diabetes and cancer biomarkers strip sensors are some factors accounting for its large share. Global disposable ...

Global disposable medical sensors market is expected to reach USD 7,543.1 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of HAIs (hospital acquired infections) and government initiatives aimed at reducing central-line associated bloodstream infections and surgical site infections in ward located and ICU patients are expected to serve the market as high impact rendering drivers. Introduction and subsequent rise in usage rates of novel technologies such as cancer tracking sensors, Hba1c sensors and MEMS pressure sensors is expected to boost future market growth. Strip sensors dominated the overall product segment in terms of revenue and were valued at USD 1,800.2 million in 2013. Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders and the consequent rise in demand for diabetes and cancer biomarkers strip sensors are some factors accounting for its large share. Browse full research ...